This role is responsible for advancing biomarker strategies to support Sail's transition into clinical development using their proprietary Endless RNA technology.
Base: $200,000 - $250,000; Bonus/Equity: Not specified; Benefits: Not specified
Must-have
Nice-to-have
Not specified